Carregant...
Function After Injection of Benign Bone Lesions with a Bioceramic
BACKGROUND: A novel calcium sulfate–calcium phosphate composite injectable bone graft substitute has been approved by the FDA for filling bone defects in a nonweightbearing application based on preclinical studies. Its utility has not been documented in the literature. QUESTIONS/PURPOSES: We therefo...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer-Verlag
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3369099/ https://ncbi.nlm.nih.gov/pubmed/22290129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11999-012-2251-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|